GANO KYLE (Chief Business Development Off) sold 20.6% of their position (36.40K shares) of NEUROCRINE BIOSCIENCES INC on the open market
Open‑market sale worth $4.83M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+34.59K
Price / share
$35.99
Trade value
$1.24M
% of position
Common Stock
Shares
−34.59K
Price / share
$132.70
Trade value
$4.59M
% of position
Common Stock
Shares
+1.81K
Price / share
$35.99
Trade value
$65.21K
% of position
Common Stock
Shares
−1.81K
Price / share
$132.71
Trade value
$240.48K
% of position
Net shares
+0.00
Net value
-$3.52M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/16/2026 | M · Option Exercise | +34.59K | $35.99 | $1.24M | 24.6% | 140.41K | 175K |
| Common Stock Direct | 1/16/2026 | S · Sale | −34.59K | $132.70 | $4.59M | 19.8% | 175K | 140.41K |
| Common Stock Direct | 1/16/2026 | M · Option Exercise | +1.81K | $35.99 | $65.21K | 1.3% | 140.41K | 142.22K |
| Common Stock Direct | 1/16/2026 | S · Sale | −1.81K | $132.71 | $240.48K | 1.3% | 142.22K | 140.41K |
| Total | +0.00 | -$3.52M | ||||||
Non-Qualified Stock Option
Common Stock
34.59K shares
Shares
−34.59K
Strike price
35.99
Held after
0.00
Exercisable
—
Incentive Stock Option
Common Stock
1.81K shares
Shares
−1.81K
Strike price
35.99
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option Direct | Common Stock34.59K shares | 1/16/2026 | M · Option Exercise | −34.59K | 35.99 | — | 0.00 |
| Incentive Stock Option Direct | Common Stock1.81K shares | 1/16/2026 | M · Option Exercise | −1.81K | 35.99 | — | 0.00 |